Amarin Corp plc (ADR) (NASDAQ:AMRN)

CAPS Rating: 3 out of 5

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.

Recs

0
Player Avatar vic929 (< 20) Submitted: 2/23/2011 2:11:34 PM : Outperform Start Price: $8.17 AMRN Score: -129.70

This will be bought by another.

Featured Broker Partners


Advertisement